Sunday, February 3, 2008
Entelos expands J&J drug discovery collaboration
Entelos, a company specializing in predictive biosimulation technologies for drug discovery, development, and commercialization, has expanded its research collaboration with Johnson & Johnson Pharmaceutical R&D, to include multiple therapeutic areas over a five-year term.
Subscribe to:
Post Comments (Atom)

No comments:
Post a Comment